Director, Oncology Global Medical Affairs Strategy & Execution (Solid Tumors)

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

The Director, Oncology Global Medical Affairs Strategy & Execution supports the strategic objectives of the J&J Innovative Medicine Oncology Global Medical Affairs (GMAF) team. This individual will partner within designated oncology disease areas ensuring cross-functional alignment and execution of GMAF data generation and communication strategies in support of the Oncology GMAF team. This includes the following:

• Generation of a consolidated GMAF strategy that meets prioritized global and regional strategic imperatives
• Medical Affairs input into product development and life-cycle management
• GMAF Team management, including coordination of cross-functional strategy meetings, Global and regional discussions, and scientific knowledge exchange forums
• Development and execution of the publication strategy/global publication plans
• Development and execution of GMAF tactics, including coordinating advisory boards, steering committees, external engagements, scientific communication platforms, and core slide decks

  The Global Medical Affairs Strategy & Execution Lead is responsible for:

  • GMA-Owned Cross-Pharma Policies and SOPs, including: Research Concept Approval Process/System (ReCAP); Publication SOP/System; Investigator-Initiated and Collaborative Studies Policy/SOP; Methods Review Process, etc.
  • Global Medical Affairs Strategy
  • Global Integrated Evidence Generation Plan
  • Consolidated Global and regional Publication Plans
  • GMA SharePoint Site Management/Scientific and Knowledge Information Management

    Additional responsibilities include:

    • Partnering with GMAF Leaders to prepare robust strategies for compounds in development that reflect prioritized regional and local needs.
    • Leading the publications planning process. Ensure publications follows the Cross-Pharma Publication Policy/SOP. Coordinate publication discussions in collaboration with agency partners and J&J stakeholders. Manage the relationship with editorial staff at key journals and key scientific and academic societies.
    • Co-leading the TA / product business planning process, including the development strategies, tactics, plan and budget. Accountable for budget oversight and working with finance to track budget and quarterly targets.
    • Providing subject matter expertise for cross-pharma standard operating procedures and processes including ReCAP, Publications, Methods Review and Collaborative / Investigator-Initiated Study (IIS) concepts.
    • Acting as standing or ad-hoc member for various cross-functional teams, provides scientific/medical and operational perspectives to the global strategic organizations.
    • Managing the development and execution of global scientific communication strategy, including scientific communication platforms, internal knowledge exchange and dissemination in partnership with GMAF Leads, Therapeutic Area VP, and Disease Area Leads, as appropriate.
    • Ensuring optimal project and vendor management in the execution of GMA strategies and tactics; develop sourcing strategies and effective partnerships with vendors/agencies and other key external partners.
    • Ensuring congress-related activities are executed, including internal company meetings, tracking of presentations, and supporting presenters